Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors
**Background:** Long-acting somatostatin analog therapy (LA-SSA) is recommended as first-line therapy for treatment of unresectable or metastatic neuroendocrine tumors (NETs). Understanding treatment sequencing and dosing patterns of LA-SSA is essential for clinical decision-making to provide value-...
Saved in:
Main Authors: | Callisia N. Clarke, Paul Cockrum, Thomas J.R. Beveridge, Michelle Jerry, Donna McMorrow, Anh Thu Tran, Alexandria T. Phan |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2023-12-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.89300 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experience
by: Ali Koyuncuer, et al.
Published: (2024-04-01) -
State-of-the art of endoscopic semeiology of neuroendocrine tumors of the stomach
by: I. B. Perfil’yev, et al.
Published: (2011-06-01) -
Outcomes after Surgery for Malignant Pancreatic Neuroendocrine Tumors
by: Omar Hama Ghalib Azeez Hawramy, et al.
Published: (2019-08-01) -
Surgical planning of small intestine neuroendocrine tumors: the concept of mesenteric tumor deposits
by: Romain L’Huillier, et al.
Published: (2025-02-01) -
Improving neuroendocrine tumor treatments with mathematical modeling: lessons from other endocrine cancers
by: John Metzcar, et al.
Published: (2025-02-01)